• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Albemarle Appoints Michelle T. Collins and Mark R. Widmar to Board of Directors

    3/2/26 4:40:00 PM ET
    $ALB
    Major Chemicals
    Industrials
    Get the next $ALB alert in real time by email

    CHARLOTTE, N.C., March 2, 2026 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced that its Board of Directors (the "Board") has appointed Michelle T. Collins and Mark R. Widmar to the Board, effective February 26, 2026. Collins will join the Board's Audit & Finance Committee and Governance & Public Policy Committee. Widmar will join the Executive Compensation & Talent Development Committee and Safety, Sustainability, Operations & Capital Committee.

    Albemarle Corp. Logo. (PRNewsFoto/Albemarle Corporation)

    Collins brings more than 40 years of audit and advisory related experience to the Board. She is a former Vice Chair, Senior Audit Partner, and National Automotive Sector Leader for Deloitte & Touche LLP, working with Deloitte's largest global clients from 1996 until her recent retirement. Ms. Collins also served on the Deloitte & Touche U.S. Board of Directors for six years where she served as Vice Chair, Chair of the Finance and Audit Committee and Chair of the Governance Committee.

    "Michelle will bring a wealth of leadership experience to the Board, honed over decades of service in audit and advisory roles," said Albemarle Chairman and CEO Kent Masters. "Her expertise in financial reporting, technology, business transformation, governance, and risk management will be a valuable asset to our Board and our shareholders."

    Widmar brings extensive executive leadership experience to the Board of Directors. Since 2016, he has served as Chief Executive Officer of First Solar, following earlier roles as the company's Chief Financial Officer and Chief Accounting Officer. Before joining First Solar, he was Chief Financial Officer at GrafTech International Ltd. from 2006 to 2011 and previously served in financial leadership roles at NCR Inc., Dell Inc., and various other global, public organizations. Widmar began his career in 1987 as an accountant with Ernst & Young.

    "Through his experience as both a CEO and CFO, Mark will bring significant public company management and board experience, along with deep knowledge in global supply chains, operations, emerging markets, and government affairs," Masters said. "His background and capabilities will benefit our Board and support Albemarle's long-term strategy." 

    The appointments of Ms. Collins and Mr. Widmar are part of the Board's regular succession planning, and reflect its continued commitment to effective oversight, strong corporate governance, and long-term value creation.

    About Albemarle 

    Albemarle Corporation (NYSE:ALB) leads the world in transforming essential resources into critical ingredients for mobility, energy, connectivity and health. We partner to pioneer new ways to move, power, connect and protect with people and planet in mind. A reliable and high-quality global supply of lithium and bromine allows us to deliver advanced solutions for our customers. Learn more about how the people of Albemarle are enabling a more resilient world at Albemarle.com.

    Albemarle regularly posts information to Albemarle.com, including notification of events, news, financial performance, investor presentations and webcasts, non-GAAP reconciliations, U.S. Securities and Exchange Commission filings and other information regarding the company, its businesses and the markets it serves.

    Forward-Looking Statements

    This press release contains statements concerning our expectations, anticipations and beliefs regarding the future, which constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements, which are based on assumptions that we have made as of the date hereof and are subject to known and unknown risks and uncertainties, often contain words such as "anticipate," "believe," "expect," "may," "should," "would," and "will" and similar references to future periods. Forward-looking statements may include statements regarding: expectations relating to Company strategy, operations, or performance; plans and expectations related to board composition and contributions; other underlying assumptions and outlook considerations, and all other information relating to matters that are not historical facts. These and other forward-looking statements are based on management's current assumptions and expectations and involve risks and uncertainties that could significantly affect expected results. Actual results could differ materially from those expressed or implied in the forward-looking statements if one or more of the underlying estimates, assumptions or expectations prove to be inaccurate or are unrealized. Factors that could cause Albemarle's actual results to differ materially from the outlook expressed or implied in any forward-looking statement include: breaches of contract; changes in economic and business conditions; changes in availability to serve on the board of directors; trade policies and tariffs; technological change and development; changes in laws and government regulation; regulatory actions, proceedings, cyber-security breaches, and the other factors detailed from time to time in the reports Albemarle files with the SEC, including those described under "Risk Factors" in Albemarle's most recent Annual Report on Form 10-K and any subsequently filed Quarterly Reports on Form 10-Q, which are filed with the SEC and available on the investor section of Albemarle's website (investors.albemarle.com) and on the SEC's website at www.sec.gov. These forward-looking statements speak only as of the date of this press release. Albemarle assumes no obligation to provide any revisions to any forward-looking statements should circumstances change, except as otherwise required by securities and other applicable laws.

    Investor Relations Contact: +1 (980) 308-6194, [email protected]

    Media Contact: Ryan Dean, +1 (980) 308-6310, [email protected]

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/albemarle-appoints-michelle-t-collins-and-mark-r-widmar-to-board-of-directors-302701566.html

    SOURCE Albemarle Corporation

    Get the next $ALB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALB

    DatePrice TargetRatingAnalyst
    2/17/2026$190.00Neutral → Buy
    BofA Securities
    1/21/2026$205.00Hold → Buy
    Truist
    1/20/2026$200.00Hold → Buy
    HSBC Securities
    1/13/2026$185.00Hold → Buy
    Deutsche Bank
    1/12/2026$200.00Sector Perform → Sector Outperform
    Scotiabank
    1/7/2026$210.00Neutral → Outperform
    Robert W. Baird
    12/16/2025$147.00Underweight → Equal-Weight
    Morgan Stanley
    12/5/2025$185.00Neutral → Buy
    UBS
    More analyst ratings

    $ALB
    SEC Filings

    View All

    SEC Form 10-K filed by Albemarle Corporation

    10-K - ALBEMARLE CORP (0000915913) (Filer)

    2/11/26 4:49:08 PM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - ALBEMARLE CORP (0000915913) (Filer)

    2/11/26 4:23:21 PM ET
    $ALB
    Major Chemicals
    Industrials

    Amendment: SEC Form SCHEDULE 13G/A filed by Albemarle Corporation

    SCHEDULE 13G/A - ALBEMARLE CORP (0000915913) (Subject)

    1/29/26 11:23:22 AM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Albemarle upgraded by BofA Securities with a new price target

    BofA Securities upgraded Albemarle from Neutral to Buy and set a new price target of $190.00

    2/17/26 8:01:23 AM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle upgraded by Truist with a new price target

    Truist upgraded Albemarle from Hold to Buy and set a new price target of $205.00

    1/21/26 8:25:13 AM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle upgraded by HSBC Securities with a new price target

    HSBC Securities upgraded Albemarle from Hold to Buy and set a new price target of $200.00

    1/20/26 8:06:42 AM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Commercial Officer Norris Eric was granted 1,806 shares and covered exercise/tax liability with 785 shares, increasing direct ownership by 2% to 48,953 units (SEC Form 4)

    4 - ALBEMARLE CORP (0000915913) (Issuer)

    3/2/26 6:03:10 PM ET
    $ALB
    Major Chemicals
    Industrials

    Chief Supply Chain Officer Mummert Mark Richard covered exercise/tax liability with 159 shares and was granted 366 shares, increasing direct ownership by 1% to 14,372 units (SEC Form 4)

    4 - ALBEMARLE CORP (0000915913) (Issuer)

    3/2/26 6:03:05 PM ET
    $ALB
    Major Chemicals
    Industrials

    Chief Bus..Transformation Off. Anderson Melissa H. was granted 1,129 shares and covered exercise/tax liability with 491 shares, increasing direct ownership by 7% to 9,512 units (SEC Form 4)

    4 - ALBEMARLE CORP (0000915913) (Issuer)

    3/2/26 5:54:34 PM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Albemarle Appoints Michelle T. Collins and Mark R. Widmar to Board of Directors

    CHARLOTTE, N.C., March 2, 2026 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced that its Board of Directors (the "Board") has appointed Michelle T. Collins and Mark R. Widmar to the Board, effective February 26, 2026. Collins will join the Board's Audit & Finance Committee and Governance & Public Policy Committee. Widmar will join the Executive Compensation & Talent Development Committee and Safety, Sustainability, Operations & Capital Committee. Collins brings more t

    3/2/26 4:40:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle Corporation Announces Cash Tender Offers for Debt Securities and Redemption of 4.650% Senior Notes due 2027

    CHARLOTTE, N.C., March 2, 2026 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced the commencement of cash tender offers for certain series of its debt securities and the full redemption of its 4.650% Senior Notes due 2027. Cash Tender OffersThe Company has commenced cash tender offers (collectively, the "Offers") for the maximum principal amount of validly tendered (and not validly withdrawn) (i) 5.650% Senior Notes due 2052 (the "2052 Notes"), (ii) 5.450% Senior Notes

    3/2/26 4:25:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle Completes Sale of Controlling Stake in Ketjen to KPS Capital Partners

    CHARLOTTE, N.C., March 2, 2026 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity, and health, today announced it has completed the sale of a controlling stake in Ketjen Corporation's refining catalyst solutions business (Ketjen) to affiliates of KPS Capital Partners, LP (KPS). Albemarle retains a minority stake in Ketjen, with KPS having a majority of the Board of Directors and operational control. Albemarle retains 100% ownership of Ketjen's Performance Catalyst Solutions business, which has been

    3/2/26 4:15:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Coleman Kristin M. bought $167,314 worth of shares (1,373 units at $121.86) (SEC Form 4)

    4 - ALBEMARLE CORP (0000915913) (Issuer)

    11/7/23 4:39:49 PM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Financials

    Live finance-specific insights

    View All

    Albemarle Announces Quarterly Common Stock Dividend

    CHARLOTTE, N.C., Feb. 26, 2026 /PRNewswire/ -- The Board of Directors of Albemarle Corporation (NYSE:ALB) today announced that it declared a quarterly common stock dividend of $0.405 per share. The dividend, which has an annualized rate of $1.62, is payable April 1, 2026, to shareholders of record at the close of business as of March 13, 2026. About Albemarle Albemarle Corporation (NYSE:ALB) leads the world in transforming essential resources into critical ingredients for mobility, energy, connectivity and health. We partner to pioneer new ways to move, power, connect and protec

    2/26/26 4:15:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle Announces Plans to Idle its Kemerton Lithium Hydroxide Processing Plant

    Decision improves financial flexibility and preserves optionality CHARLOTTE, N.C., Feb. 11, 2026 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced it will idle the remaining operating train, Train 1, at its Kemerton lithium hydroxide processing plant in Western Australia and place it into care and maintenance effective immediately. Today's announcement follows actions in 2024 to place Train 2 into care and maintenance and to cease expansion plans for Trains 3 and 4.

    2/11/26 4:20:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle Reports Fourth Quarter and Full Year 2025 Results

    CHARLOTTE, N.C., Feb. 11, 2026 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter and Full Year 2025 Results and Highlights(Unless otherwise stated, all percentage changes represent year-over-year comparisons) Fourth quarter net sales of $1.4 billion, up 16%; volume up 12%, including gains in all segments led by Energy Storage (up 17%) and Ketjen (up 13%).Fourth quarter net loss of

    2/11/26 4:15:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Albemarle Corporation

    SC 13G/A - ALBEMARLE CORP (0000915913) (Subject)

    12/5/24 7:27:01 PM ET
    $ALB
    Major Chemicals
    Industrials

    SEC Form SC 13G filed by Albemarle Corporation

    SC 13G - ALBEMARLE CORP (0000915913) (Subject)

    11/13/24 12:52:42 PM ET
    $ALB
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by Albemarle Corporation

    SC 13G/A - ALBEMARLE CORP (0000915913) (Subject)

    11/13/24 10:27:59 AM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Leadership Updates

    Live Leadership Updates

    View All

    Albemarle Appoints Michelle T. Collins and Mark R. Widmar to Board of Directors

    CHARLOTTE, N.C., March 2, 2026 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced that its Board of Directors (the "Board") has appointed Michelle T. Collins and Mark R. Widmar to the Board, effective February 26, 2026. Collins will join the Board's Audit & Finance Committee and Governance & Public Policy Committee. Widmar will join the Executive Compensation & Talent Development Committee and Safety, Sustainability, Operations & Capital Committee. Collins brings more t

    3/2/26 4:40:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    Ketjen Announces the Appointment of Henri Tausch as Chief Commercial Officer

    Ketjen Corporation, a leader in catalyst and specialty chemicals manufacturing, today announces the appointment of Henri Tausch to Chief Commercial Officer (CCO) effective June 24, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240619765799/en/Henri Tausch, Ketjen Chief Commercial Officer (Photo: Business Wire) In his role as Chief Commercial Officer, Tausch will oversee and advance the company's commercial strategy, and foster key partnerships to accelerate the company's global growth trajectory. "I am honored to join Ketjen and contribute to its continued success," said Henri Tausch "It's inspiring to see Ketjen's dedi

    6/19/24 7:00:00 AM ET
    $ALB
    Major Chemicals
    Industrials

    International Paper Announces Changes to Its Board of Directors

     Jamie A. Beggs and Scott A. Tozier to Join as Newest Board Members Ilene S. Gordon to Retire from the Board MEMPHIS, Tenn., May 22, 2024 /PRNewswire/ -- International Paper ("IP") (NYSE:IP) announced that Jamie A. Beggs and Scott A. Tozier have been elected to IP's Board of Directors, effective May 21, 2024. The company also announced that Ilene S. Gordon has retired from the Board citing personal and health reasons, effective May 21, 2024. Ms. Beggs, age 47, currently serves as Senior Vice President and Chief Financial Officer of Avient Corporation (NYSE:AVNT), a premier pr

    5/23/24 10:51:00 AM ET
    $ALB
    $AVNT
    $IP
    Major Chemicals
    Industrials
    Paper
    Basic Materials